Access Statistics for Mary K. Olson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Pharmaceutical Expenditure and Regulatory Policy in the NHS 0 0 0 0 0 0 0 329
Total Working Papers 0 0 0 0 0 0 0 329


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Agency Rulemaking, Political Influences, Regulation, and Industry Compliance 0 0 0 0 1 1 1 350
Are novel drugs more risky for patients than less novel drugs? 0 1 1 26 0 1 4 97
Eliminating the U.S. drug lag: Implications for drug safety 0 0 1 10 1 3 9 84
Examining Firm Responses to R&D Policy: An Analysis of Pediatric Exclusivity 0 0 1 1 4 6 15 16
Firm Characteristics and the Speed of FDA Approval 0 0 0 38 0 0 4 126
Pharmaceutical Policy Change and the Safety of New Drugs 0 0 0 3 1 1 2 45
Political Influence and Regulatory Policy: The 1984 Drug Legislation 0 0 0 0 0 1 2 172
Regulatory Agency Discretion among Competing Industries: Inside the FDA 0 0 0 0 0 1 3 172
Regulatory Reform and Bureaucratic Responsiveness to Firms: the Impact of User Fees in the FDA 0 0 0 24 0 0 1 112
Substitution in Regulatory Agencies: FDA Enforcement Alternatives 0 0 0 0 0 0 0 189
The Effects of UK Pharmaceutical Policy on Government Drug Expenditure: Cost Control and Incentives for R&D 0 0 0 12 0 0 0 62
The risk we bear: The effects of review speed and industry user fees on new drug safety 0 0 0 22 1 1 1 111
Total Journal Articles 0 1 3 136 8 15 42 1,536


Statistics updated 2019-10-05